Home › Funds › Farallon Capital Management › BSX

Farallon Capital Management position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Latest position (Q2 2026)10.52M sh
Reported value held$449.04M
Portfolio Weight2.08%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 14.00M $607.57M New
Q4 2021 16.81M $714.28M Add
Q1 2022 15.74M $697.14M Reduce
Q2 2022 15.05M $560.81M Reduce
Q3 2022 12.15M $470.62M Reduce
Q4 2022 9.26M $428.47M Reduce
Q1 2023 7.71M $385.49M Reduce
Q2 2023 5.05M $272.90M Reduce
Q3 2023 5.04M $266.07M Hold
Q4 2023 5.82M $336.47M Add
Q1 2024 4.60M $314.83M Reduce
Q2 2024 4.11M $316.45M Reduce
Q3 2024 5.43M $454.67M Add
Q4 2024 5.02M $448.65M Reduce
Q1 2025 3.76M $379.59M Reduce
Q2 2025 3.98M $427.61M Add
Q3 2025 4.75M $463.41M Add
Q4 2025 7.44M $709.36M Add
Q1 2026 7.47M $468.79M Hold
Q2 2026 10.52M $449.04M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding BSX

All BSX fund holders →